Exploris Health
About Exploris Health
Exploris Health harnesses artificial intelligence to develop precise, non-invasive diagnostic and therapy solutions that accelerate accurate diagnoses and enhance treatment outcomes in cardiovascular health.
Founded in 2018 and headquartered in Wallisellen, Zürich, the company specializes in AI-based diagnostics and therapy solutions with a particular focus on coronary artery disease and heart failure.
Solutions
Their flagship products include the Cardio Explorer, a non-invasive test that reliably detects life-threatening narrowing of the coronary arteries (coronary artery disease), and the Heart Failure Explorer for personalized therapy of heart failure patients.
They offer AI as a service with a platform enabling rapid analysis of complex data structures and development of new applications in healthcare.
Partners and Accreditations
Exploris Health collaborates with various clinical institutions and partners, including Microsoft, Roche, University Hospital Basel, and Maastricht University Medical Centre.
The Cardio Explorer test is certified for use in the EU and UK and the company has achieved ISO 13485 certification, demonstrating a commitment to quality management in medical device manufacturing.
